Karen Cashmere

Karen Cashmere

Company: Zyversa Therapeutics, Inc.

Job title: Chief Commercial Officer

Seminars:

Identifying The Optimal Therapeutic Applications for Your Inflammasome Inhibitor – Avoid InfiniteThink! 9:00 am

Therapeutic options for inflammasome inhibitors seem infinite – this presentation will address key considerations for narrowing the list to those with the highest potential for clinical and commercial success Disease pathogenesis Models for preclinical proof-of-concept Unmet medical and patient needs Differentiation from current and pipeline competitorsRead more

day: Day Two

8.50 | Chair’s Opening Remarks
8:50 am

Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.